BAY3547922
/ Bayer
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
April 14, 2025
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers
(clinicaltrials.gov)
- P1 | N=14 | Completed | Sponsor: Bayer | Active, not recruiting ➔ Completed
Trial completion • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
March 25, 2025
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers
(clinicaltrials.gov)
- P1 | N=14 | Active, not recruiting | Sponsor: Bayer | Recruiting ➔ Active, not recruiting
Enrollment closed • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
March 11, 2025
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
(clinicaltrials.gov)
- P1 | N=148 | Recruiting | Sponsor: Bayer | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
February 11, 2025
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
(clinicaltrials.gov)
- P1 | N=148 | Not yet recruiting | Sponsor: Bayer | Trial completion date: Feb 2029 ➔ Dec 2033 | Trial primary completion date: Nov 2027 ➔ Jul 2030
Trial completion date • Trial primary completion date • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
January 08, 2025
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
(clinicaltrials.gov)
- P1 | N=148 | Not yet recruiting | Sponsor: Bayer
New P1 trial • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
September 20, 2024
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers
(clinicaltrials.gov)
- P1 | N=17 | Recruiting | Sponsor: Bayer | Not yet recruiting ➔ Recruiting
Enrollment open • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
June 12, 2024
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer
(clinicaltrials.gov)
- P1 | N=17 | Not yet recruiting | Sponsor: Bayer | Trial completion date: Aug 2024 ➔ Nov 2024 | Trial primary completion date: Aug 2024 ➔ Nov 2024
Trial completion date • Trial primary completion date • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
April 03, 2024
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer
(clinicaltrials.gov)
- P1 | N=17 | Not yet recruiting | Sponsor: Bayer
New P1 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
1 to 8
Of
8
Go to page
1